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New Technologies to Advance
Self-Management Support in Diabetes
Not just a bunch of cool apps!
T
he article by Walker et al. (1) in this
issue of Diabetes Care highlights
how new applications of existing
modes of communication and the use of
new technologies can improve the deliv-
ery of care for patients with diabetes. In
thiscase,carewassuccessfullybroughtto
a poorly controlled patient group using
the medium of live telephone calls. New
types of technology-based interventions
focus on the use of the telephone, Internet,
mobile communicators, pagers, web-based
programs, and email to assess and monitor
patient health status, address symptoms
and behaviors, and foster changes in vari-
ousaspectsofdiseasemanagement—inthis
case better medication adherence and im-
proved glycemic control.
The purpose of these emerging sys-
tems is to expand programs of self-
management support (SMS), a generic
termappliedtostrategiesthatprovidepa-
tients with the information, tools, and
support they need to take care of their
health problems (2,3). The development
andapplicationofaspectrumofinterven-
tions that involve new media expand
evidence-based methods of patient
monitoring and intervention that tradi-
tionally have taken place within the clin-
ical setting to real-world environments in
ways that are congruent with patient life-
style, age, and cultural setting (3,4). The
underlying assumption is that such pro-
grams can be more successful, sustain-
able, and cost- and time-efﬁcient than
traditional approaches and that they have
the potential to reach high risk patient
populationsthatgenerallydonotcometo
their doctor’s ofﬁce for regular care (3,5).
These SMS programs vary in complexity,
fromsimpletelephone-basedprogramsof
symptom monitoring to highly elaborate,
web-based programs with complex
branching algorithms that assist patients
with improving self-care over time (6).
The increased popularity of these pro-
grams,coupledwithreal-worldquestions
about their practical usability in clinical
care, cost, sustainability, and effective-
ness, cause us to reﬂect on how such pro-
gramsshouldbetranslatedforgeneraluse
and integrated into care for patients with
diabetes. Now that the ﬁeld has matured
by the variety of available evidence-based
technological SMS programs currently
available, the need to establish criteria for
translation into the real-world of clinical
care is apparent (4). Sadly, too often such
programs are supported by time-limited
external resources, and even if proven ef-
fective, they are shelved when the project
is completed because they cannot easily
be integrated and supported by ongoing
care systems.
In this editorial, we provide a per-
spective for surveying this expanding
ﬁeld by reviewing a template of ﬁve inter-
related questions that summarize the ma-
jor translational issues for SMS programs
based on new technologies (Table 1).
Without such consideration, we risk not
taking full advantage of the unique
strengths and not avoiding the potential
drawbacks of these programs to improve
outcomes for patients with diabetes.
What is the speciﬁc purpose of the
SMS program?
What is often missing in the selection and
use of SMS systems in clinical care is the
clear targeting of speciﬁc goals: what ex-
actly is the target of the program and how
will it be achieved? Are there multiple
SMS goals to be addressed or is the focus
more narrowly drawn? For example, the
telephone-based intervention designed
by Walker et al. was concisely focused on
reducing A1C, as are many SMS systems
for patients with diabetes. In this case,
however, a speciﬁc proximal mechanism
of change was designed into the interven-
tion: enhancing medication adherence.
Many existing SMS programs are devel-
oped without this kind of clear outcome
targeting, meaning that a speciﬁc behav-
ioral domain and a sequencing of behav-
ioral change goals are not identiﬁed at the
outset. SMS programs are often devel-
oped to address only the distal goal of
improved glycemic control by using a
proximal goal of weight reduction, in-
creased physical activity, or medication
adherence. Proximal change goals, how-
ever, are rarely assessed comprehensively
or seen as major outcomes in their own
right, because the primary aim is change
in A1C, the distal goal. This is an impor-
tant consideration, because it is entirely
possible that the proximal goal, in this
case medication adherence, could have
been achieved without being followed by
achievementofthedistalgoal,inthiscase
areductioninA1C.Whenthisoccurs,the
intervention is often deemed a failure,
even though the actual behavioral change
targetedwasachieved.Manyfactorsaffect
glycemic control, and changes in one po-
tential inﬂuence may be insufﬁcient to
signiﬁcantly affect A1C, especially over
the course of time involved in clinical tri-
als. As a general rule, it is crucial to judge
the effectiveness and utility of a speciﬁc
SMSinterventionbyobservingchangesto
both proximal and distal targets, and not
to rely solely on changes to a distal out-
come that can be inﬂuenced by multiple
factors, such as A1C.
A related issue is time frame: can the
change targeted be achieved by a deﬁned
but time-limited intervention, or will it
require a longer-lasting program that in-
cludes a greater investment in patient en-
gagement,intervention,andsupport?For
example,Walkeretal.foundthatchanges
in medication adherence were achievable
withinthelimitedtimeframeofthestudy.
In contrast, major reductions in body
weight, the target of many SMS interven-
tions with new technologies, require
much longer time periods, supplemented
by ongoing programs to maintain weight
lossovertime.ManySMSprogramsusing
new technologies demonstrate initial suc-
cess and then stop, with a subsequent re-
turn to preintervention levels because
they did not consider that achieving and
maintaining behavioral change is not a
one-time experience. Both diabetes and
disease management are chronic condi-
tions requiring ongoing support and in-
tervention, which can be a major strength
of new technologies if addressed and in-
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outset. In the current example, it remains
unclear if the documented improvement
inmedicationadherencecanbesustained
and whether the SMS program will need
tobealteredtoassistwithmaintenanceof
medication adherence over time.
Which patients are to be targeted?
The greater the effort devoted to deﬁning
the patient population of interest, the
bettertheoutcomes,thehighertheaccep-
tance rate, and the lower the attrition (7).
Tailoring SMS interventions for speciﬁc
patientgroupsincreasestheprobabilityof
obtaining positive results. For example,
simply making a web-based program
available to everyone may be beneﬁcial
because it is inclusive, but the lack of tai-
loringwilloftenexcludemanyofthemost
needy or high risk patients who could
proﬁtmostfromtheintervention.Thecri-
teria identiﬁed for inclusion in the pro-
gram reported by Walker et al. were
speciﬁc: these were patients who were
poorly controlled, rarely came for care,
identiﬁed with a respected institution
(their Union), and were generally from a
single ethnic group. Much effort was de-
voted to using cultural cues to engage
these patients, and the Union was used as
a common, trusted institution to enhance
reach. The success of these efforts was re-
vealed by high patient uptake and rela-
tively low attrition over time. Even the
choice of media was carefully considered:
this was a sample that might best be en-
gaged via live contact through the tele-
phone rather than, for example, through
interactive voice recognition (IVR) tech-
nologies or web-based/email programs,
even though they are far less expensive to
deliver. A comparable program for pa-
tients from another ethnic group or from
another education level might best be de-
signed quite differently. One-size-ﬁts-all
SMS programs may be relatively inexpen-
sive for an entire patient panel, but they
are often highly inefﬁcient with respect to
high risk patients who need them the
most. At minimum, we suggest that the
following patient characteristics should
be considered when making use of new
technologies: age, sex, ethnicity, educa-
tion, severity of disorder or symptoms,
level of risk, and experience with and
preference for different media.
Which media and media
characteristics will be utilized?
ManycurrentlyavailableSMSsystemsus-
ingnewtechnologiesarecomplexandso-
phisticated in terms of available options
and ability to be customized both within
and across different media. Some empha-
size programs to engage patients in the
process and to assist in the maintenance
of gains over time (8). Still others allow
for “stepped interventions,” for different
levels of intervention intensity based on
patientneedorpreference,orformultiple
interventions, with patients choosing the
speciﬁc goals and subprograms (9). Al-
though this sophistication is attractive,
much of it will be often underused when
the program is translated into clinical
practice with a large, diverse panel of pa-
tients. Most patients access only a limited
number of features in complex SMS pro-
grams (10,11). Although many programs
are elegant, the usability, accessibility,
andtargetingofspeciﬁcgoalsforbothpa-
tients and care teams may be best (12).
Not all media are equally effective for
all types of SMS programs, and careful
consideration needs to be directed at de-
ciding which medium is best for which
intervention and for which patients. For
example, IVR technology has been used
successfullyforsymptommonitoringand
for relatively short and simple communi-
cations between patient and care team,
such as clinical status reporting (13).
However, IVR programs can be tedious
and repetitious for more complex tasks,
where web-based audio and visual cues
can be more helpful and patients can re-
main engaged for longer time periods.
Consequently, there needs to be a careful
match between each speciﬁc SMS pro-
gram target, the clinical population iden-
tiﬁed, and the medium selected for use. A
single intervention program cannot easily
be translated across different media with
the assumption that one can be substi-
tuted for another. And not all patients
with diabetes will be equally attracted to
the same program.
Anotherimportantissueconcernsthe
amount of live versus automated patient
contact included in the program. Al-
though costs are generally higher with
Table 1—SMS Questions
1. What is the speciﬁc purpose of the SMS program?
a. What are the proximal and distal goals? Is the focus behavior change, clinical status, or
symptom monitoring?
b. Can behavior change and maintenance be achieved in a time-limited way, or will it be
gradual, requiring ongoing support?
c. Is the SMS goal comprehensive or highly targeted (intensive vs. extensive intervention)?
2. Which patients will be targeted?
a. Demographics: age, ethnicity, gender.
b. Severity of disorder or symptoms.
c. Level of risk.
d. Level of media experience and preference (personal and cultural).
3. Which media and media characteristics will be utilized?
a. Media (web, email, telephone, etc.)?
b. How many bells and whistles (level of program complexity).
c. Is this a stepped intervention, does one program ﬁt all?
d. What is the ratio of human to technological contact (balancing the cost of human
contact)?
e. How much emphasis is there on patient engagement and maintenance?
4. Will the SMS program be integrated into the patient’s ongoing clinical care?
a. Where does the program come from (the practice, health plan, employer, or stand-alone
source)?
b. Too what degree is the program built around relationships between patients and HCPs
or staff? Or is this a carved-out, stand-alone program?
c. How and by whom (clinicians, staff, patients) will the information generated by the
program be used?
d. How will the program be framed for patients, clinicians, and practice staff?
5. Costs.
a. Who will support the program ﬁnancially, e.g., clinical practice, health plan, patient,
medical group?
b. What are the development costs?
c. What are the initial costs for customizing and implementing the program in each setting?
d. What are the ongoing costs of use over time (information technology staff to maintain
the program, clinical staff to make use of the information, etc.)?
e. Are there patient costs?
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deciding to utilize less live contact with
some patient groups may not be cost-
efﬁcient. The ideal balance of live to tech-
nological contact is often based on the
patient’s cultural context, level of risk,
age, and life context. To reduce cost, per-
sonal contact can be utilized initially and
then decreased over time, depending on
patient need, once a relationship with the
live program representative has been es-
tablished. And patient preference can be
utilized in tailoring a program—some pa-
tients actually prefer fully automated sys-
tems, whereas others ﬁrmly do not. For
example, one highly experienced com-
puter user surprisingly rejected a web-
based program: “I spend my entire day
working on the computer and when I get
homeIdon’tevenwanttolookatmyPC.”
Although a totally automated program
may be effective for a subset of the popu-
lation, a well-balanced, ﬂexible, patient-
tailored level of live contact generally
appeals to a wider audience and may
prove to be most effective in terms of cost
and clinical outcome.
How will the SMS program be
integrated into the patient’s ongoing
clinical care?
How integrated and seamless is the SMS
system with respect to the broader deliv-
ery of the patient’s diabetes care? Most
currently available SMS programs are
free-standing; they are not easily inte-
grated within ofﬁce-based electronic
health records and other automated clin-
ical care systems, or patients seek them
out on their own, which leaves the SMS
activity completely separated from the
care team. Still others are offered by an
employer or a health insurance plan with
no direct linkage to the diabetes care
team. In the study reported by Walker, et
al., the SMS program was designed to op-
erate independently of the patient’s regu-
lar care team. When translated into the
real-world of clinical care, how would
health care practitioners (HCPs) know
about such a system and make effective
use of it when caring for individual
patients?
The growing interest in integrated
systemsofcare,modeledafterthePatient-
Centered Medical Home (14–16), sug-
gests a need to provide more coordinated
and informed services in collaboration
with patient need and preference. As
these new models of primary care have
gained acceptance and traction, practices
areshowingincreasedinterestinintegrat-
ing SMS programs of various types into
their care. Free-standing or carved-out
SMS programs stand in sharp contrast to
these recent developments and raise con-
cerns about the pitfalls of fragmented
care, especially for high risk patients with
diabetes. In general, patients are far more
likely to continue with an SMS program
over time when it is based on a positive
relationshipwiththeirHCPandwhenitis
viewed as an extension of their care (17).






Deciding upon the adoption of an
SMS system that uses new technologies
also requires careful consideration of
workﬂow—howtheinformationderived
fromthesystemwillbecollected,summa-
rized, and used in the clinical setting.
Who in the ofﬁce will monitor patient
SMS activities recorded by the program?
How will the information be documented
in the medical record? How will it be
practicallysummarizedforuseduringthe
next clinical encounter or red-ﬂagged for
a more immediate response? SMS infor-
mation adds to already high staff de-
mands to integrate a great deal of clinical
information needed for good diabetes
care (18).
What is the development and
implementation cost and how will




tutes of Health and the Union pension
fund. From a translation perspective, no
information is provided about the overall
costs of program development, imple-
mentation, and long-term use. In the real
worldofclinicalcare,itoftenremainsun-
clear who will shoulder the various
substantial costs of SMS programs: the
clinic, the medical group, the health care
plan, the employer, the patient? And how
will the program be framed for the pa-
tient—isthistheirdoctor’sprogram,their
health plan’s program, their employer’s
program? This framing, based in part on
whodesignsandpaysforit,canhavesub-
stantial effects on patient follow-through
and outcome. It is important that SMS
outcome studies track and report infor-
mation regarding the cost of develop-
ment, implementation, and maintenance
to inform decisions regarding the optimal
deployment of the program on an ongo-
ing basis.
CONCLUSIONS — SMS programs
for patients with diabetes make use of the
full range of electronic media, from sim-
ple automated telephone monitoring to
more complex, web-based lifestyle
changeprograms.Mostoftheseprograms
have evolved outside of the traditional
care system and others were developed
internally but often lack the resources to
be maintained over time. Care systems
have been relatively slow to adopt SMS
programsandtointegratethemintomore
comprehensive care for patients with dia-
betes. The pressing need to deliver cost-
effective, population-based care that
reaches out to the individual needs of pa-
tients with diabetes calls for practitioners
to become proactive in selecting and cus-
tomizing efﬁcient, semi- and fully auto-
mated SMS programs. The program
described in the paper by Walker, et al.
serves as an excellent model, but it also
raises important questions. Using a vari-
ety of different media, these programs
have the potential for expanding care
from traditionally delivered ofﬁce-based
encounters to care that reaches into the
patient’s home and community. These
programsrequirethatcliniciansengagein
active and systematic consideration of the
patients who might use it, the speciﬁc
SMS behaviors that are targeted for
change, the type of media that will be
used, the time frame of the program, who
will pay for it, and how the program will
be integrated into a broader program of
comprehensive diabetes care.
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